Le Lézard
Classified in: Health, Business
Subject: FNC

GI Windows Raises $16.4M in Series A-1 Financing


WEST BRIDGEWATER, Mass., Aug. 19, 2020 /PRNewswire/ -- GI Windows Medical Corp, a clinical-stage, privately-held medical device company, announced a $16.4 million Series A-1 financing. The financing attracted Johnson & Johnson Innovation ? JJDC, Inc., along with Sonder Capital, GT Healthcare, JC Investco and one additional strategic investor.  In addition to the institutional financing, GI Windows also received investments from existing shareholders as well as new investors, the Kennedy Trust and Coleman Trust. The proceeds will be used to support further product development and clinical studies for GI Window's patented technology.

"We are thrilled to have this opportunity to support GI Windows in the development of GI Window's transformative technology.  We believe this technology will set a new standard by improving safety, accelerating healing and reducing post-surgical complications," said John Cammett, Managing Director of JC Investco.  "The GI Windows technology has the potential to create a new paradigm for assessing risk profiles in surgical procedures, improving access to care and enabling new procedures to make a tremendous impact on patients," said Andy McGibbon, Partner at Sonder Capital. "The Sonder Capital team is excited to continue as part of this story."

"We are excited by the support of our investors" said Brian Tinkham, President and Chief Executive Officer of GI Windows. "Our team continues to reinvent the future of healthcare with product development and demonstrating consistent efficacy and safety in our clinical trials.  We are on an unwavering mission to improve clinical outcomes and reduce healthcare costs for patients and providers."

About GI Windows
GI Windows Corp is a clinical-stage, venture-backed medical device company dedicated to developing the first fundamental breakthrough in anastomoses technology in both delivery and tissue fusion. The company was spun out of Beacon Endoscopic (acquired by Covidien in 2014).  GI Window's is currently headquartered in West Bridgewater, MA.

Contact Information: 

Media Contact:
[email protected]

SOURCE GI Windows


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: